The World Health Organization suspended its trials with the malaria drug hydroxychloroquine and the combination of the HIV drug lopinavir / ritonavir to treat COVID-19 patients in hospital after failing to lower mortality rates, Al Jazeera reported.
"These interim study results show that hydroxychloroquine and lopinavir / ritonavir hardly, or not at all, reduce the mortality rate of COVID-19 patients in hospital compared to the standard of care. The investigators of the solidarity study will interrupt the studies with immediate effect," the WHO was quoted like saying in a statement.
The WHO added that this decision will now affect the other studies where the drugs are not used in hospitals or for prophylaxis.
The WHO has now reported a total of 212,326 new cases of coronavirus worldwide within 24 hours.
The agency also reported that 5,134 deaths have been reported in the last 24 hours, increasing the total number of victims to 523,011.
WHO declared the COVID-19 outbreak a pandemic on March 11.
(Except for the headline, this story was not edited by NDTV staff and published from a syndicated feed.)